MicroRNA-Related Polymorphisms in Infectious Diseases-Tiny Changes With a Huge Impact on Viral Infections and Potential Clinical Applications

• Published in: Frontiers in immunology Vol. 9; p. 1316
• Main Authors: Ellwanger, Joel Henrique, Zambra, Francis Maria Báo, Guimarães, Rafael Lima, Chies, José Artur Bogo
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 14-06-2018
• Subjects: hepatitis B virus; hepatitis C virus; human immunodeficiency virus; Immunology; microRNA; miR; polymorphism; hepatitis B virus; human papillomavirus; miR; hepatitis C virus; human immunodeficiency virus; microRNA; polymorphism; Epstein–Barr virus
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2018.01316

MicroRNAs (miRNAs) are single-stranded sequences of non-coding RNA with approximately 22 nucleotides that act posttranscriptionally on gene expression. miRNAs are important gene regulators in physiological contexts, but they also impact the pathogenesis of various diseases. The role of miRNAs in viral infections has been explored by different authors in both population-based as well as in functional studies. However, the effect of miRNA polymorphisms on the susceptibility to viral infections and on the clinical course of these diseases is still an emerging topic. Thus, this review will compile and organize the findings described in studies that evaluated the effects of genetic variations on miRNA genes and on their binding sites, in the context of human viral diseases. In addition to discussing the basic aspects of miRNAs biology, we will cover the studies that investigated miRNA polymorphisms in infections caused by hepatitis B virus, hepatitis C virus, human immunodeficiency virus, Epstein-Barr virus, and human papillomavirus. Finally, emerging topics concerning the importance of miRNA genetic variants will be presented, focusing on the context of viral infectious diseases.